A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. (Q53811577)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

title

A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

0 references

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

Giorgia Valpiani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Luca Degli Esposti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

Ezio Degli Esposti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

Mirko Di Martino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

Stefania Saragoni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

Stefano Buda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

Alessandro Capone

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

Alessandra Sturani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

1347-57; discussion 1346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Blood-pressure control in the hypertensive population

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Daily regimen and compliance with treatment

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Long-term persistence with antihypertensive drugs in new patients

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Using healthcare claims data for outcomes research and pharmacoeconomic analyses

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Why we need observational studies to evaluate the effectiveness of health care

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

The use of claims databases for outcomes research: rationale, challenges, and strategies

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Continuation of initial antihypertensive medication after 1 year of therapy.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

The assessment of refill compliance using pharmacy records: methods, validity, and applications

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Utility of a transdermal delivery system for antihypertensive therapy. Part 2.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Long-term surveillance for adverse effects of antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Clinicians and patients with hypertension: Unsettled issues about compliance

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1016/S0149-2918(02)80039-X

7 January 2021

10.1016/S0149-2918(02)80039-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12240784 AND SRC:MED&resulttype=core&format=json

release_o2b2gi5x3vdjrag6ibf5upp434

13 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o2b2gi5x3vdjrag6ibf5upp434

24 November 2022

mapped directly with Wikidata item

1 reference